Lyra Influenza A+B Assay
Influenza A And Influenza B Multiplex Nucleic Acid Assay. 510(k) K230236, from Quidel Corporation (San Diego, CA). Product code OZE, class 2.
As of Nov 20, 2026, K230236 is an FDA 510(k) held by Quidel Corporation, substantially equivalent on Mar 3, 2023 after 32 days, with no recalls tied to it in FDA's recall database.
- Review time: 32 days
- Recalls: 0
The Lyra Influenza A+B Assay is a multiplex Real Time RT-PCR assay for the in vitro qualitative detection and differentiation of influenza A and influenza B viral RNA in nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection.
- Quidel Molecular Influenza A + B AssayK131728 · Quidel Corp. · Aug 29, 2013
- CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel (includes Influenza A/B Typing Kit, Influenza A Subtyping…K263035 · Centers for Disease Control and Prevention · Sep 30, 2026
- CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2); Influenza A SubTyping…K243274 · Centers for Disease Control and Prevention · Jul 11, 2025
- CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2); Influenza A Subtyping…K243931 · Centers for Disease Control and Prevention · Mar 14, 2025
- CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A Subtyping Kit (Ver4)K241110 · Centers for Disease Control and Prevention · May 21, 2024
- ID Now Instrument, ID Now Influenza A & B 2, ID NOW Strep A 2K220801 · Abbott Diagnostics Scarborough, Inc. · Jun 24, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jan 30, 2023
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3980
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files